Tolerance of an Immersive Virtual Reality Task Evaluating the Spatial Memory of Elderly Subjects
NCT ID: NCT05996250
Last Updated: 2024-06-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
84 participants
INTERVENTIONAL
2023-09-25
2024-05-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Before being able to test its possible diagnostic efficacy, it is imperative to test the feasibility as well as the reliability of this type of task on an elderly population with no cognitive impairment. The data currently available on immersion tolerance in virtual reality mainly concern young people aged 18 to 35 and little data is available concerning the elderly or very old.
If this task correctly assesses spatial navigation abilities, this study should find the effects of age and sex usually observed.
The aim of this study is to assess the tolerance of an immersive virtual reality task evaluating the spatial memory of elderly subjects and the effects of age, gender and level of education on performance.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Usability of Virtual Reality in Subjects With Mild Cognitive Impairment or Alzheimer's Disease
NCT02176629
Cognitive Remediation VR Tool for People With MCI: a Feasibility RCT
NCT06270966
Effects of the Fully Immersive Leisure-based Virtual Reality Cognitive Training for Community-dwelling Elderly
NCT05227495
Virtual Reality Training for Inhibitory Control in Neurocognitive Disorders
NCT06597591
Usability, Acceptability, and Safety of Virtual Reality-based Cognitive Intervention
NCT05583903
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Immersive virtual reality task
The immersive virtual reality task, specifically designed for this research, is an adaptation to humans of Morris Pool. The virtual environment is composed of a circular arena 22 virtual meters in diameter, delimited by a low wall. It features two visual landmarks and an invisible object to find. The activity includes a control training sequence, an evaluation sequence and a delayed recall performed approximately 20 minutes after the end of the evaluation sequence.
The immersive reality task is performed once by the participants (the study consists on one visit).
Immersive virtual reality task
participants will have to wear a virtual reality headset connected to a remote control and will have to perform submersive virtual reality tasks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Immersive virtual reality task
participants will have to wear a virtual reality headset connected to a remote control and will have to perform submersive virtual reality tasks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participant affiliated or entitled to a social security scheme
* Recruited participants must have been informed and consented in writing
Exclusion Criteria
* Severe, progressive or unstable pathology whose nature may interfere with the evaluation variables (epilepsy, psychiatric or psychotic disorders in the acute phase, visual hallucinations, acute infection, lack of sleep)
* Participant equipped with a pacemaker
* Burns or sores on the upper part of the face or on the scalp
* Consumption of toxic substances that can influence cognitive performance
* Deafness or blindness that may compromise participant assessment or completion of tasks and scales
* Participant under guardianship or curatorship or legal safeguard
* Participant refusing to use an immersive virtual reality tool
* Criterion for stopping the procedure under study: stopping the virtual reality task due to the participant's simulator sickness.
* Montreal Cognitive Assessment (MOCA) score less than 26
* MacNair Subjective Complaint Scale score greater than 16
* AGGIR score (Autonomy, Gerontology Group Iso Resources) less than 5
60 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charpennes Geriatric Hospital, Lyon University Hospital
Villeurbanne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL22_0203
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.